Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: James P who wrote (1060)	6/2/1998 5:03:00 PM
From: J. Malek Baroody	Respond to of 2887

Back to Business. From today's Investor's Business Daily front page. NEWS FOR YOU Emerging Ways To Treat Carotid Arteries Noninvasive Methods Show Good Results In Clinical Tests Date: 6/2/98 Author: Cynthia Drake Concerned that you're at risk for a ''brain attack''? More than half a million Americans suffer strokes each year, says the American Heart Association, which recently gave strokes this nickname. At least 20% of these brain attacks are caused by a narrowing in the carotid arteries. These are the arteries on the left and right sides of the body that supply the majority of blood used by the brain. When a carotid becomes stenosed -narrowed by arteriosclerosis, the plaque that builds up in arteries - the condition can be a precursor to a stroke. To date, this narrowing of the artery has been treated by a surgical procedure, carotid endarterectomy. But now researchers are working on clinical tests of an alternative treatment that uses stents like those employed with angioplasty. Stents are tiny implantable devices that hold arteries open. For this less-invasive treatment of narrowed carotids, doctors use internal catheters and balloons without making an incision in the neck. The procedure is similar to the methods frequently used to treat a narrowing of the heart's coronary arteries...... Register for free to access todays paper investors.com